N-[1-[(Z)-4-amino-2-fluorobut-2-enyl]-3-(2,6-dimethyl-4-pyridinyl)-2-methylindol-5-yl]methanesulfonamide
C21H25FN4O2S — CID 130302712
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-[(Z)-4-amino-2-fluorobut-2-enyl]-3-(2,6-dimethyl-4-pyridinyl)-2-methylindol-5-yl]methanesulfonamide
N-[1-[(Z)-4-amino-2-fluorobut-2-enyl]-3-(2,6-dimethyl-4-pyridinyl)-2-methylindol-5-yl]methanesulfonamide (PubChem CID 130302712) has the molecular formula C21H25FN4O2S and a molecular weight of 416.52 g/mol. Its IUPAC name is N-[1-[(Z)-4-amino-2-fluorobut-2-enyl]-3-(2,6-dimethyl-4-pyridinyl)-2-methylindol-5-yl]methanesulfonamide.
Molecular Properties
| Compound Name | N-[1-[(Z)-4-amino-2-fluorobut-2-enyl]-3-(2,6-dimethyl-4-pyridinyl)-2-methylindol-5-yl]methanesulfonamide |
|---|---|
| PubChem CID | 130302712 |
| Molecular Formula | C21H25FN4O2S |
| Molecular Weight | 416.52 g/mol |
| Exact Mass | 416.17 |
| IUPAC Name | N-[1-[(Z)-4-amino-2-fluorobut-2-enyl]-3-(2,6-dimethyl-4-pyridinyl)-2-methylindol-5-yl]methanesulfonamide |
| SMILES | Cc1cc(-c2c(C)n(C/C(F)=C/CN)c3ccc(NS(C)(=O)=O)cc23)cc(C)n1 |
| InChI | InChI=1S/C21H25FN4O2S/c1-13-9-16(10-14(2)24-13)21-15(3)26(12-17(22)7-8-23)20-6-5-18(11-19(20)21)25-29(4,27)28/h5-7,9-11,25H,8,12,23H2,1-4H3/b17-7- |
| InChIKey | IKBVLJQUKOAAGC-IDUWFGFVSA-N |
| XLogP | 3.81 |
| TPSA | 90.01 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 416.52 |
| LogP ≤ 5 | 3.81 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 130302712 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.